Lidoflazine has been available abroad for over 15 years, and is now being marketed here for the treatment of angina pectoris. It is a piperazine derivative chemically unrelated to any other anti-anginal drug and its mode of action is uncertain.
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.